Aktuális sajtó tartalmak és illusztrációs fotók

clot prevention képek

641 találat
  • / 17
  • kép/oldal:
RF
PARIS, FRANCE - MARCH 4, 2026: Close-up of an Eliquis apixaban medicine box in a household in Paris, France, a prescription anticoagulant used for str-stock-foto
RF
CVA Cerebrovascular Accident text written on notepad with magnifying glass and alarm clock on wooden background-stock-foto
RF
Atherosclerosis Stages Infographic Showing Artery Plaque Formation, Growth, Rupture, and Blood Clot Development in Human Circulatory System.-stock-foto
RF
Haemophilia Awareness Week. Background, poster, postcard, banner design.-stock-foto
RF
Haemophilia Awareness Week. banner for social media post-stock-foto
RF
Plaque Ruptures and Coronary Artery Blockage.-stock-foto
RF
CVA symbol. Wooden cubes with words CVA Cerebrovascular accident. Beautiful deep blue background. Healthcare and Cerebrovascular accident concept. Cop-stock-foto
RF
CVA symbol. Wooden cubes with words CVA Cerebrovascular accident. Beautiful deep blue background. Healthcare and Cerebrovascular accident concept. Cop-stock-foto
RF
Ischemic stroke vector illustration-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto